Proton magnetic resonance spectroscopy in portal-systemic encephalopathy

被引：19

作者：

Köstler, H ^{[1
]}

机构：

[1] Hannover Med Sch, Dept Neuroradiol, D-30623 Hannover, Germany

来源：

METABOLIC BRAIN DISEASE | 1998年 / 13卷 / 04期

关键词：

magnetic resonance spectroscopy; portal-systemic encephalopathy; hepatic encephalopathy;

D O I：

10.1023/A:1020632708154

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Localized proton magnetic resonance spectroscopy (MRS) with short echo times provides unique information of human cerebral metabolism. Studies on patients with portal-systemic encephalopathy (PSE) have been performed to clarify the pathogenesis of this disease and to find a method which allows an objective diagnosis. Spectra of patients with PSE show typical abnormalities. Regional variations of these spectral changes are observed. The metabolic changes correlate with the grade of encephalopathy but the dependence on the Child-Pugh score is controversial. No causal dependence between MRS findings and abnormalities in magnetic resonance imaging is evident. Differences in magnetic resonance spectra in patients compared to controls vanish after liver transplantation, but increase after TIPS. The results of proton magnetic resonance spectroscopy are important for an understanding of the pathogenesis of PSE, but do not aid in the diagnosis of subclinical hepatic encephalopathy.

引用

页码：291 / 301

页数：11

共 57 条

[1]

BECKER G, 1994, SOC MAGN RESON, V2, P570

[2] PROTON MR SPECTROSCOPY FOR DIAGNOSING HEPATIC-ENCEPHALOPATHY [J].

BOTTOMLEY, PA .

RADIOLOGY, 1992, 182 (01) :6-7

[3] SPATIAL LOCALIZATION IN NMR-SPECTROSCOPY INVIVO [J].

BOTTOMLEY, PA .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 508 :333-348

[4]

BRUHN H, 1991, HEPATOLOGY, V14, P121

[5]

BRUHN H, 1991, SOC MAGN RESON MED, V100, P400

[6]

BRUNO M, 1993, ECON TRANSIT, V1, P5

[7] AMMONIA - KEY FACTOR IN THE PATHOGENESIS OF HEPATIC-ENCEPHALOPATHY [J].

BUTTERWORTH, RF ;

GIGUERE, JF ;

MICHAUD, J ;

LAVOIE, J ;

LAYRARGUES, GP .

NEUROCHEMICAL PATHOLOGY, 1987, 6 (1-2) :1-12

[8]

CHAMULEAU RAFM, 1994, ADV EXP MED BIOL, V368, P23

[9] WHAT THE CLINICIAN CAN LEARN FROM MR GLUTAMINE GLUTAMATE ASSAYS [J].

CHAMULEAU, RAFM ;

BOSMAN, DK ;

BOVEE, WMMJ ;

LUYTEN, PR ;

DENHOLLANDER, JA .

NMR IN BIOMEDICINE, 1991, 4 (02) :103-108

[10]

DANIELSEN ER, 1995, SOC MAGN RESON, V3, P1839

← 1 2 3 4 5 6 →